Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrin Dadkhah

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|October 19, 2021
Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate DocumentationAdrin Dadkhah, Dzenefa Alihodzic, Astrid Broeker, et al.
Frontiers in Oncology|November 30, 2023
Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairmentFranziska Marquard, Claudia Langebrake, Dietlinde Janson, et al.
Transplantation and Cellular Therapy|November 14, 2021
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Adrin Dadkhah, Dietlinde Janson, et al.
Transplantation and Cellular Therapy|October 14, 2022
Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Marco Heestermans, Adrin Dadkhah, et al.
International Journal of Pharmaceutics|July 19, 2023
Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospitalMoritz Rosch, Tobias Gutowski, Michael Baehr, et al.
Bone Marrow Transplantation|April 14, 2026
Busulfan pharmacokinetics in adults - a real-world evaluation of intra-individual variability and the impact of obesity and deferasiroxClaudia Langebrake, Eva-Maria A Wansing, Dietlinde Janson, et al.
Pharmaceutics|June 24, 2022
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell TransplantationAdrin Dadkhah, Sebastian Georg Wicha, Nicolaus Kröger, et al.
Sensors (Basel, Switzerland)|July 30, 2025
Opportunities and Limitations of Wrist-Worn Devices for Dyskinesia Detection in Parkinson's DiseaseAlexander Johannes Wiederhold, Qi Rui Zhu, Sören Spiegel, et al.
Clinical Pharmacology and Therapeutics|November 12, 2025
Cystatin C-based eGFR better predicts renal vancomycin clearance than creatinine-based eGFR in patients with allogeneic stem cell transplantationEva-Maria A Wansing, Sebastian G Wicha, Peter Bannas, et al.
International Journal of Pharmaceutics: X|September 2, 2025
Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in childrenAdrin Dadkhah, Tobias Gutowski, Eva-Maria Wansing, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|October 19, 2021
Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate DocumentationAdrin Dadkhah, Dzenefa Alihodzic, Astrid Broeker, et al.
Frontiers in Oncology|November 30, 2023
Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairmentFranziska Marquard, Claudia Langebrake, Dietlinde Janson, et al.
Transplantation and Cellular Therapy|November 14, 2021
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Adrin Dadkhah, Dietlinde Janson, et al.
Transplantation and Cellular Therapy|October 14, 2022
Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Marco Heestermans, Adrin Dadkhah, et al.
International Journal of Pharmaceutics|July 19, 2023
Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospitalMoritz Rosch, Tobias Gutowski, Michael Baehr, et al.
Bone Marrow Transplantation|April 14, 2026
Busulfan pharmacokinetics in adults - a real-world evaluation of intra-individual variability and the impact of obesity and deferasiroxClaudia Langebrake, Eva-Maria A Wansing, Dietlinde Janson, et al.
Pharmaceutics|June 24, 2022
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell TransplantationAdrin Dadkhah, Sebastian Georg Wicha, Nicolaus Kröger, et al.
Sensors (Basel, Switzerland)|July 30, 2025
Opportunities and Limitations of Wrist-Worn Devices for Dyskinesia Detection in Parkinson's DiseaseAlexander Johannes Wiederhold, Qi Rui Zhu, Sören Spiegel, et al.
Clinical Pharmacology and Therapeutics|November 12, 2025
Cystatin C-based eGFR better predicts renal vancomycin clearance than creatinine-based eGFR in patients with allogeneic stem cell transplantationEva-Maria A Wansing, Sebastian G Wicha, Peter Bannas, et al.
International Journal of Pharmaceutics: X|September 2, 2025
Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in childrenAdrin Dadkhah, Tobias Gutowski, Eva-Maria Wansing, et al.
Pageof 2